- Home
- CMAX vs NURO Comparison
CMAX vs NURO Comparison
Compare CMAX & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMAX
- NURO
- Stock Information
- Founded
- CMAX 2011
- NURO 1996
- Country
- CMAX United States
- NURO United States
- Employees
- CMAX N/A
- NURO N/A
- Industry
- CMAX Computer Software: Prepackaged Software
- NURO Medical/Dental Instruments
- Sector
- CMAX Technology
- NURO Health Care
- Exchange
- CMAX Nasdaq
- NURO Nasdaq
- Market Cap
- CMAX 7.6M
- NURO 8.2M
- IPO Year
- CMAX N/A
- NURO N/A
- Fundamental
- Price
- CMAX $1.85
- NURO $4.55
- Analyst Decision
- CMAX Hold
- NURO
- Analyst Count
- CMAX 2
- NURO 0
- Target Price
- CMAX $33.20
- NURO N/A
- AVG Volume (30 Days)
- CMAX 58.0K
- NURO 15.0K
- Earning Date
- CMAX 11-07-2024
- NURO 11-01-2024
- Dividend Yield
- CMAX N/A
- NURO N/A
- EPS Growth
- CMAX N/A
- NURO N/A
- EPS
- CMAX N/A
- NURO N/A
- Revenue
- CMAX $784,551,000.00
- NURO $4,383,614.00
- Revenue This Year
- CMAX $13.01
- NURO N/A
- Revenue Next Year
- CMAX $32.42
- NURO N/A
- P/E Ratio
- CMAX N/A
- NURO N/A
- Revenue Growth
- CMAX 9.06
- NURO N/A
- 52 Week Low
- CMAX $1.55
- NURO $2.66
- 52 Week High
- CMAX $74.70
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- CMAX 46.01
- NURO 65.06
- Support Level
- CMAX $1.60
- NURO $3.96
- Resistance Level
- CMAX $2.39
- NURO $4.69
- Average True Range (ATR)
- CMAX 0.19
- NURO 0.22
- MACD
- CMAX 0.07
- NURO 0.04
- Stochastic Oscillator
- CMAX 32.50
- NURO 82.35
About CMAX CareMax Inc.
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.